Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy.

Acute diffuse and total alopecia of the female scalp albeit on immunossupression. Int J Trichology (2017) 0.75

The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta (2011) 5.72

IL-6: regulator of Treg/Th17 balance. Eur J Immunol (2010) 3.82

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood (2008) 2.62

The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets (2007) 2.17

New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res (2002) 1.42

Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for a regulatory role of IL-6, IL-7, TNF beta, and UVB light. J Invest Dermatol (1992) 1.02

In vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101. Clin Exp Dermatol (2005) 0.85

Multiple halo naevi associated with tocilizumab. Clin Exp Dermatol (2014) 0.83